Gritstone bio (GRTS) Stock Price, News & Analysis
Company Description
Gritstone bio (NASDAQ: GRTS) is classified in the biological product (except diagnostic) manufacturing industry within the Biological Products, (no Disgnostic Substances) sector and carries a market capitalization of $3.8M, ranking #7,044 among all listed U.S. companies by market cap.
GRTS has declined 98.4% over the past year. Shares last traded at $0.0322.
This page collects what Stock Titan holds for GRTS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Gritstone bio (GRTS) stock last closed at $0.0322. Over the past 12 months, the stock has lost 98.4%. At a market capitalization of $3.8M, GRTS is classified as a micro-cap stock.
GRTS Rankings
Latest News
Gritstone bio has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, conferences, covid-19. View all GRTS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GRTS Company Profile & Sector Positioning
Gritstone bio (GRTS) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.